Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

11 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
ACE inhibitor-induced angioedema.
Vasekar M, Craig TJ. Vasekar M, et al. Curr Allergy Asthma Rep. 2012 Feb;12(1):72-8. doi: 10.1007/s11882-011-0238-z. Curr Allergy Asthma Rep. 2012. PMID: 22127615 Review.
Immunotherapy in Bladder Cancer.
Vasekar M, Degraff D, Joshi M. Vasekar M, et al. Curr Mol Pharmacol. 2016;9(3):242-251. doi: 10.2174/1874467208666150716120945. Curr Mol Pharmacol. 2016. PMID: 26177642 Review.
Emerging molecular therapies for the treatment of acute lymphoblastic leukemia.
Vasekar M, Allen JE, Joudeh J, Claxton D. Vasekar M, et al. Adv Exp Med Biol. 2013;779:341-58. doi: 10.1007/978-1-4614-6176-0_16. Adv Exp Med Biol. 2013. PMID: 23288648 Review.
Novel Immunotherapies for Hematological Malignancies.
Vasekar M, Rizvi S, Liu X, Vrana KE, Zheng H. Vasekar M, et al. Curr Mol Pharmacol. 2016;9(3):264-271. doi: 10.2174/1874467208666150716121253. Curr Mol Pharmacol. 2016. PMID: 26177640 Review.
Relationship of smoking status to genomic profile, chemotherapy response and clinical outcome in patients with advanced urothelial carcinoma.
Joshi M, Vasekar M, Grivas P, Emamekhoo H, Hsu J, Miller VA, Stephens PJ, Ali SM, Ross JS, Zhu J, Warrick J, Drabick JJ, Holder SL, Kaag M, Li M, Pal SK. Joshi M, et al. Among authors: vasekar m. Oncotarget. 2016 Aug 9;7(32):52442-52449. doi: 10.18632/oncotarget.9449. Oncotarget. 2016. PMID: 27213592 Free PMC article.
Targeted immunotherapy for non-small cell lung cancer.
Vasekar M, Liu X, Zheng H, Belani CP. Vasekar M, et al. World J Clin Oncol. 2014 May 10;5(2):39-47. doi: 10.5306/wjco.v5.i2.39. World J Clin Oncol. 2014. PMID: 24829850 Free PMC article. Review.
Recent advances in pancreatic cancer: updates and insights from the 2015 annual meeting of the American Society of Clinical Oncology.
Abrams MJ, Rakszawski K, Vasekar M, Passero F, Abbas A, Jia Y, Saif MW. Abrams MJ, et al. Among authors: vasekar m. Therap Adv Gastroenterol. 2016 Mar;9(2):141-51. doi: 10.1177/1756283X15622601. Therap Adv Gastroenterol. 2016. PMID: 26929776 Free PMC article. No abstract available.
ATM/RB1 mutations predict shorter overall survival in urothelial cancer.
Yin M, Grivas P, Emamekhoo H, Mendiratta P, Ali S, Hsu J, Vasekar M, Drabick JJ, Pal S, Joshi M. Yin M, et al. Among authors: vasekar m. Oncotarget. 2018 Mar 30;9(24):16891-16898. doi: 10.18632/oncotarget.24738. eCollection 2018 Mar 30. Oncotarget. 2018. PMID: 29682192 Free PMC article.
Postoperative chemotherapy and radiation improve survival following cardiac sarcoma resection.
Hendriksen BS, Stahl KA, Hollenbeak CS, Taylor MD, Vasekar MK, Drabick JJ, Conte JV, Soleimani B, Reed MF. Hendriksen BS, et al. Among authors: vasekar mk. J Thorac Cardiovasc Surg. 2019 Nov 28:S0022-5223(19)32223-8. doi: 10.1016/j.jtcvs.2019.10.016. Online ahead of print. J Thorac Cardiovasc Surg. 2019. PMID: 31928808
Prognostic Value of DNA Damage Response Genomic Alterations in Relapsed/Advanced Urothelial Cancer.
Yin M, Grivas P, Wang QE, Mortazavi A, Emamekhoo H, Holder SL, Drabick JJ, Woo MS, Pal S, Vasekar M, Folefac E, Clinton SK, Monk P, Joshi M. Yin M, et al. Among authors: vasekar m. Oncologist. 2020 Apr 10;25(8):680-8. doi: 10.1634/theoncologist.2019-0851. Online ahead of print. Oncologist. 2020. PMID: 32275806 Free PMC article.
11 results
Jump to page
Feedback